Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma
Clinical trial NCT04698213 · UNKNOWN
Trial details
- NCT number
- NCT04698213
- Sponsor
- Consorzio Oncotech
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-07
- Primary completion
- 2023-09-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.